Meglitinides increase the risk of hypoglycemia in diabetic patients with advanced chronic kidney disease: a nationwide, population-based study

The safety of short-acting meglitinides in diabetic patients with advanced chronic kidney disease (CKD) has not been widely reported. Diabetic patients with advanced CKD who had a serum creatinine level of > 6 mg/dL a hematocrit level of ≦ 28% and received erythropoiesis-stimulating agent treatme...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Wu, Pei-Chen, Wu, Vin-Cent, Lin, Cheng-Jui, Pan, Chi-Feng, Chen, Chih-Yang, Huang, Tao-Min, Wu, Che-Hsiung, Chen, Likwang, Wu, Chih-Jen
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
Clinical Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652839/
https://ncbi.nlm.nih.gov/pubmed/29100450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17475
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky